Related Experiment Video
Updated: Jun 19, 2026

06:35
Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Parachlorella beyerinckii accelerates lead excretion in mice
Takuya Uchikawa1, Takeyuki Ueno, Takashi Hasegawa
1Chlorella Industry Co. Ltd, Chikugo, Fukuoka, Japan.
Toxicology and Industrial Health
|October 15, 2009
Summary
Parachlorella beyerinckii powder (BP) significantly reduced lead absorption in mice. BP administration increased lead excretion and lowered lead levels in blood, liver, and kidneys, suggesting its potential for lead exposure mitigation.
Area of Science:
- Environmental Toxicology
- Microbiology
- Bioremediation
Background:
- Lead exposure poses significant health risks due to its toxicity.
- Parachlorella beyerinckii CK-5, a microalga, has shown potential in biological applications.
- Investigating the efficacy of microalgae in mitigating heavy metal toxicity is crucial.
Purpose of the Study:
- To evaluate the effect of Parachlorella beyerinckii powder (BP) on gastrointestinal lead absorption in mice.
- To determine the impact of BP on lead excretion and accumulation in key organs.
- To assess the in vitro lead adsorption capacity of BP.
Main Methods:
- Female ICR mice were orally administered lead acetate with or without BP.
- Lead levels in feces, blood, liver, and kidneys were measured using atomic absorption spectrometry.
- In vitro lead adsorption assays were performed using BP and its pepsin non-digestive residue (dBP).
Main Results:
- BP administration significantly increased fecal lead excretion by 17.2-27.7% compared to controls.
- Lead levels in blood, liver, and kidneys were reduced by 48-63% in BP-treated mice.
- In vitro studies showed BP adsorbed 10.6 mg of lead per 100 mg, and dBP adsorbed 6.0 mg per 100 mg.
Conclusions:
- Parachlorella beyerinckii powder effectively reduces gastrointestinal lead absorption and promotes lead excretion in mice.
- BP demonstrates significant lead adsorption capabilities, both in vivo and in vitro.
- BP holds potential as a therapeutic agent for managing lead exposure in animals and humans.

